• Laura P Hurley, Sean T O'Leary, Lauri E Markowitz, Lori A Crane, Jessica R Cataldi, Michaela Brtnikova, Brenda L Beaty, Carol Gorman, Elissa Meites, Megan C Lindley, and Allison Kempe.
• From Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO (LPH, STO, LAC, JRC, MB, BLB, CG, AK); Division of General Internal Medicine, Denver Health, Denver, CO (LPH); Department of Pediatrics, Children's Hospital-Colorado, Aurora, CO (STO, JRC, MB, AK); National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA (LEM, EM, MCL); Department of Community and Behavioral Health, University of Colorado Anschutz Medical Campus, Aurora, CO (LAC). Laura.Hurley@dhha.org.
• J Am Board Fam Med. 2021 Jan 1; 34 (1): 162170162-170.

IntroductionIn June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision making (SCDM) regarding human papillomavirus (HPV) vaccination for adults 27 to 45 years. Our objectives were to assess among primary care physicians 1) recent practice regarding HPV vaccination for adults 27 to 45 years, 2) knowledge of HPV and the new SCDM recommendation, and 3) attitudes toward and anticipated effect of the new SCDM recommendation.MethodsFrom October to December 2019, we administered an Internet and mail survey to national networks of 494 general internist (GIM) and 474 family physician (FP) members of the American College of Physicians and American Academy of Family Physicians, respectively.ResultsResponse rate was 64% (617/968; GIM, 57%; FP, 71%). Fifty-eight percent were aware of the new ACIP recommendation; 42% had recommended HPV vaccination to adults 27 to 45 years, but most had administered HPV vaccine to very few of these patients (73% to 0% and 22% to 1 to 3). Fifty-five percent and 63% were unaware that HPV vaccination does not prevent progression of existing HPV-related cancers or infections, respectively and 57% were not sure what to emphasize when having a SCDM conversation about HPV vaccination. A majority reported they will be more likely recommend HPV vaccination to adults in the 27-to-45-year age range as a result of the new recommendation.ConclusionsPhysicians are interested in recommending HPV vaccination for adults age 27 to 45 years despite ACIP not routinely recommending it in this age range. The majority need more education about the optimal use of HPV vaccine in this age group.© Copyright 2021 by the American Board of Family Medicine.

21 keywords...

hide…